The CMS and FDA have been actively promoting proposed rule changes, rolling out new programs and adopting new technologies in an effort to advance the US healthcare system and modernize their agencies. From efforts to increase transparency, waivers to experiment, and adoption of Artificial Intelligence, these agencies are taking action. The team discusses some of these activities and what the impact could be to the healthcare industry.
Previous Podcast
20 April 2018
Let’s Make a Deal
About Vynamic
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Want to learn more? Get in touch!
Related Podcasts:
Advancing Health Equity in Life Sciences: Panel Recap
Industry leaders discuss breaking barriers in health equity, inclusive research, and patient access at Inizio’s NYC panel.
Read moreEuropean Healthcare Innovation Roadshow: France’s AI Revolution in Healthcare
France is making waves in AI-driven healthcare—scaling fast, innovating boldly, and balancing Silicon Valley agility...
Listen nowHCP and Consumer Omnichannel Transformation
Vynamic enabled omnichannel marketing, AI-driven sales, and governance, boosting HCP engagement, consumer reach, and sales impact.
Read more